Published 10/02/2023 9:00:02 a.m.

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Summary by Ground News

About 1.5 million Americans suffer from rheumatoid arthritis, a chronic disease. Drugs such as Humira and Enbrel block a molecule called tumor necrosis factor alpha. MyMD-1 can be taken as a tablet, rather than injection or infusion, and its molecules are small.

0 Articles

All

Left

Center

Right

The Baltimore Sun

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Researchers at MyMD, a Baltimore-based pharmaceutical company, think they’ve developed a new drug to treat rheumatoid arthritis that is safer than others on the market.

10/02/2023 9:00:02 a.m.·Baltimore, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center1Last Updated10/02/2023 9:04:38 a.m.Bias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

0 Articles

0 Articles

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics